VITALE, Candida
VITALE, Candida
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia
2015-01-01 P. Strati; W.G. Tong; C. Vitale; W.G. Wierda; S. O’Brien; J.R. Brown; W.K. Weng; T. Kipps; M.J. Keating; A. Ferrajoli
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia
2019-01-01 Visentin A.; Deodato M.; Mauro F.R.; Autore F.; Reda G.; Vitale C.; Molica S.; Rigolin G.M.; Piazza F.; Cesini L.; Tedeschi A.; Laurenti L.; Cassin R.; Coscia M.; Cuneo A.; Foa R.; Semenzato G.; Trentin L.
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells
2019-01-01 Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia
2016-01-01 Vitale, Candida; Jabbour, Elias; Lu, Xinyan; Yabe, Mariko; Shamanna, Rashmi Kanagal; Daver, Naval; Pemmaraju, Naveen; Bueso-Ramos, Carlos E.; Takahashi, Koichi*
Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives
2019-01-01 Marta Coscia, Candida Vitale, Marco Cerrano, Enrico Maffini, Luisa Giaccone, Mario Boccadoro, Benedetto Bruno
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
2015-01-01 Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M.
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs
2020-01-01 Vitale C.; Montalbano M.C.; Salvetti C.; Boccellato E.; Griggio V.; Boccadoro M.; Coscia M.
Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib
2016-01-01 Vitale, Candida; Ahn, Inhye E.; Sivina, Mariela; Ferrajoli, Alessandra; Wierda, William G.; Estrov, Zeev; Konoplev, Sergej N.; Jain, Nitin; O’Brien, Susan; Farooqui, Mohammed; Keating, Michael J.; Wiestner, Adrian; Burger, Jan A.*
B-cell Acute Lymphoblastic Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Lenalidomide
2021-01-01 Moritz Fürstenau, Anna Maria Fink, Anke Schilhabel, Jonathan Weiss, Sandra Robrecht, Robert Eckert, Javier de la Serna, Marta Crespo, Marta Coscia, Candida Vitale, Sebastian Böttcher, Gesche Weppner, Matthias Ritgen, Stephan Stilgenbauer, Eugen Tausch, Kirsten Fischer, Michael Hallek, Barbara Eichhorst, Monika Brüggemann, Carmen Diana Herling
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial
2011-01-01 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL
2010-01-01 A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL
2011-01-01 Tedeschi, A; Coscia, M; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, C; Vismara, E; Gaidano, G; Morra, E; Massaia, M; Montillo, M
Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial
2011-01-01 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia
2022-01-01 Perutelli, Francesca; Montalbano, Maria Chiara; Boccellato, Elia; Coscia, Marta; Vitale, Candida
Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia
2014-01-01 Candida Vitale; Mona Lisa Alattar; Maria Ciccone; Mahmoud R Gaballa; Xavier C Badoux; George Manoukian; Michael J Keating; Michael H Kroll; Alessandra Ferrajoli
Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia
2015-01-01 Alattar, Mona Lisa; Ciccone, Maria; Gaballa, Mahmoud R.; Vitale, Candida; Badoux, Xavier C.; Manoukian, George; Keating, Michael J.; Kroll, Michael H.; Ferrajoli, Alessandra*
CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences
2020-01-01 Vitale C.; Strati P.
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights
2022-01-01 Salvetti, Chiara; Vitale, Candida; Griggio, Valentina; Drandi, Daniela; Jones, Rebecca; Bonello, Lisa; Bomben, Riccardo; Bragoni, Alberto; Bagnara, Davide; Fais, Franco; Gattei, Valter; Cavallo, Federica; Zamò, Alberto; Coscia, Marta
CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results
2019-01-01 D'Arena G.; Valvano L.; Vitale C.; Coscia M.; Statuto T.; Bellesi S.; Lamorte D.; Musto P.; Laurenti L.; D'Auria F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia | 2015 | P. Strati; W.G. Tong; C. Vitale; W.G. Wierda; S. O’Brien; J.R. Brown; W.K. Weng; T. Kipps; M.J. Keating; A. Ferrajoli | |
| A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia | 2019 | Visentin A.; Deodato M.; Mauro F.R.; Autore F.; Reda G.; Vitale C.; Molica S.; Rigolin G.M.; Piazza F.; Cesini L.; Tedeschi A.; Laurenti L.; Cassin R.; Coscia M.; Cuneo A.; Foa R.; Semenzato G.; Trentin L. | |
| Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 2019 | Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia | 2016 | Vitale, Candida; Jabbour, Elias; Lu, Xinyan; Yabe, Mariko; Shamanna, Rashmi Kanagal; Daver, Naval; Pemmaraju, Naveen; Bueso-Ramos, Carlos E.; Takahashi, Koichi* | |
| Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives | 2019 | Marta Coscia, Candida Vitale, Marco Cerrano, Enrico Maffini, Luisa Giaccone, Mario Boccadoro, Benedetto Bruno | |
| Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma | 2015 | Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M. | |
| Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs | 2020 | Vitale C.; Montalbano M.C.; Salvetti C.; Boccellato E.; Griggio V.; Boccadoro M.; Coscia M. | |
| Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib | 2016 | Vitale, Candida; Ahn, Inhye E.; Sivina, Mariela; Ferrajoli, Alessandra; Wierda, William G.; Estrov, Zeev; Konoplev, Sergej N.; Jain, Nitin; O’Brien, Susan; Farooqui, Mohammed; Keating, Michael J.; Wiestner, Adrian; Burger, Jan A.* | |
| B-cell Acute Lymphoblastic Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Lenalidomide | 2021 | Moritz Fürstenau, Anna Maria Fink, Anke Schilhabel, Jonathan Weiss, Sandra Robrecht, Robert Eckert, Javier de la Serna, Marta Crespo, Marta Coscia, Candida Vitale, Sebastian Böttcher, Gesche Weppner, Matthias Ritgen, Stephan Stilgenbauer, Eugen Tausch, Kirsten Fischer, Michael Hallek, Barbara Eichhorst, Monika Brüggemann, Carmen Diana Herling | |
| Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL | 2010 | A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL | 2011 | Tedeschi, A; Coscia, M; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, C; Vismara, E; Gaidano, G; Morra, E; Massaia, M; Montillo, M | |
| Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo | |
| Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia | 2022 | Perutelli, Francesca; Montalbano, Maria Chiara; Boccellato, Elia; Coscia, Marta; Vitale, Candida | |
| Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia | 2014 | Candida Vitale; Mona Lisa Alattar; Maria Ciccone; Mahmoud R Gaballa; Xavier C Badoux; George Manoukian; Michael J Keating; Michael H Kroll; Alessandra Ferrajoli | |
| Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia | 2015 | Alattar, Mona Lisa; Ciccone, Maria; Gaballa, Mahmoud R.; Vitale, Candida; Badoux, Xavier C.; Manoukian, George; Keating, Michael J.; Kroll, Michael H.; Ferrajoli, Alessandra* | |
| CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences | 2020 | Vitale C.; Strati P. | |
| Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights | 2022 | Salvetti, Chiara; Vitale, Candida; Griggio, Valentina; Drandi, Daniela; Jones, Rebecca; Bonello, Lisa; Bomben, Riccardo; Bragoni, Alberto; Bagnara, Davide; Fais, Franco; Gattei, Valter; Cavallo, Federica; Zamò, Alberto; Coscia, Marta | |
| CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results | 2019 | D'Arena G.; Valvano L.; Vitale C.; Coscia M.; Statuto T.; Bellesi S.; Lamorte D.; Musto P.; Laurenti L.; D'Auria F. |